Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS Correlation with Pathologic Grade in Renal Masses
NCT03821376Phase 4Terminated
- Sponsor
- Indiana University
- Start
- Jul 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sulfur hexafluoride in renal cell carcinoma (RCC), sponsored by Indiana University. Primary endpoints: Time to Peak at 6 months, Mean Transit Time at 6 months and 1 more. Started Jul 2019; status: terminated.
02
Drugs
sulfur hexafluoride
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT03821376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03821376.